secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001493152-23-032138
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MyMD grants 1M options to President/CMO; salary raised to $500k
---------------------------------------------------------------

- Options to purchase 1,000,000 shares at $0.81 per share, vesting on clinical milestones over 12 months.
- Annual base salary set at $500,000 retroactive to Jan 1, 2023, under amended employment agreement.
- Dr. Chapman must devote majority of efforts to the Company.
- Options granted under the 2021 Equity Incentive Plan approved by compensation committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/0001493152-23-032138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer